What Is the Endocannabinoid System and What Is Its Role?

 


The endocannabinoid system (ECS) refers to a unique molecular system that is responsible for balancing and regulating several physiological processes in the body such as immune response, appetite, communication between cells, metabolism, and memory.

Through this system, cannabinoids can interact with the metabolic enzymes and receptors in the body to trigger the therapeutic effects.

In spite of the integral role played by the endocannabinoid system in our body, it was discovered only recently. The importance of the endocannabinoid system is also being understood by researchers and the medical community only in the past few decades.

The ECS involves 3 basic components: endocannabinoids, enzymes, and receptors.

Contrary to what most people believe, these 3 components of ECS are active in the body even when a person does not use cannabis or CBD oils. This marks why it is important to be aware of the role of ECS and the therapeutic benefits it offers to regulate the physiological processes.

Endocannabinoids

Endocannabinoids are molecules secreted by the body. They are similar to cannabinoids in CBD oil and help the internal functions of the body to run smoothly. These molecules are produced by the body as needed, which is why it can be difficult to find the optimum levels needed by a person.

Endocannabinoid receptors

Endocannabinoid receptors are found throughout the body. These receptors bind to endocannabinoids signaling the ECS to take action.

Endocannabinoids may target the receptors in the spinal nerves to relieve pain or bind to the receptors in the immune cells to indicate the body is experiencing inflammation.

Enzymes

Enzymes are responsible for the breakdown of endocannabinoids once they have carried out their intended functions.

The functions of ECS can contribute to homeostasis and restore the stability of the body’s internal environment.

It is important for physicians, nurses, and healthcare practitioners to be aware of the role of ECS in the management of health disorders. The abnormalities related to the ECS can increase the risk of several disorders linked to inflammation and immunological dysfunctions.

Hence, there is a need to assess the efficiency of ECS in patients with inflammatory, and autoimmune disorders to help them derive long-term relief from the symptoms such as pain and promote faster recovery.

You can learn more about ECS and its role in maintaining health by joining ‘15 AARC Approved CEU Webinar’ on both respiratory medicine and integrative medicine topics from 17th October to 20th October 2020 from 3 pm to 8 pm.

Some other topics we will discuss during the webinar include the right to die with dignity, triage healthcare assessment techniques, asthma and airway remodeling, aromatherapy for stress reduction, and the benefits of CBD oil.

You will also learn about the therapeutic uses of hypothermia, ethical delivery of hospital emergency services, acute lung injury, and ARDS.

You can interact with our panel of expert physicians and ask questions after the presentation.

Join the webinar to learn what ECS means and what the latest research studies have revealed about ECS, CBD oils, aromatherapy, asthma, airway remodeling, and much more. 

Popular posts from this blog

RESPIRATORY THERAPY TOPICS ON SLEEP MEDICINE WEBINAR

A & T Lectures Sleep Medicine Webinar Respiratory Conference that is considered live or traditional CEU’s. You can interact and ask questions after the presentation. Hosted by A & T Lectures Using Zoom Video Communications We will be offering 5 Live/Webinar AARC approved CEU’s October 22 @ 4:00 pm - 9:00 pm  CONFERENCE SCHEDULE AND INSTRUCTION ON ACCESSING THIS WEBINAR Register for the conference Special note: You can join the conference for free but only those that register will get the 5 CEU’s Download ZOOM to your computer or laptop/desktop (its free) Practice using ZOOM with a friend before entering the webinar as this will not be the right time to teach you how to access the conference Make sure you join the webinar by accessing this link 10 minutes before the conference. Join The Webinar
Read more

Pulmonary Fibrosis – Symptoms, Causes, Stages, and Treatment

Image
Pulmonary fibrosis is a lung disorder that occurs when the tissues in the lungs become damaged followed by scarring. Scaring results in the formation of thick and stiff tissue that makes it more difficult for the lungs to expand and relax preventing them from working properly. As pulmonary fibrosis becomes worsens, the patient becomes short of breath in a progressive manner. The scarring linked to pulmonary fibrosis is often caused due to a combination of factors. However, in most cases, it is difficult to detect the exact cause that triggered the development of this condition. When no specific cause can be found, the condition is called idiopathic pulmonary fibrosis. The damage caused due to pulmonary fibrosis cannot be reversed. However, medications and treatment may sometimes help to ease the symptoms and improve the patient's quality of life. In some patients, a lung transplant may be required. Stages of pulmonary fibrosis Stage 1: Recent diagnosis The common early
Read more

Management Of Respiratory Failure In COVID Patients

Image
Management Of Respiratory Failure In COVID Patients It’s been more than 8 months now and still, the COVID-19 pandemic shows no sign of decline in the number of cases. What makes the COVID-19 pandemic a major cause of concern is the high risk of mortality associated with it, particularly due to respiratory failure. COVID-19 has a higher tropism for the lung and is known to cause severe pneumonia and ARDS (acute respiratory distress syndrome), especially in patients with a weak immune system and existing co-morbidities. This marks the need for the physicians, nurses, and healthcare workers to stay abreast of the latest information about the risk of ARDS and the recommended protocol for the management of respiratory distress in COVID-19 patients. Clinical features of ARDS in COVID-19 patents Most patients with COVID-induced respiratory distress meet the Berlin definition of ARDS. However, some patients may exhibit a different phenotype of ARDS with lower lung weight, higher lu
Read more